Research Article

Machine Learning for Predicting Distant Metastasis of Medullary Thyroid Carcinoma Using the SEER Database

Table 1

The detailed demographic information of the patients with MTC.

CategoriesWith DM (n = 138)Without DM (n = 1911) value

Age, n (%)<0.001
 <5547 (34.1%)959 (50.2%)
 ≥5591 (65.9%)952 (49.8%)
Gender (n%)<0.001
 Female50 (36.2%)1149 (60.1%)
 Male88 (63.8%)762 (39.9%)
Race (n%)0.891
 White116 (84.1%)1619 (84.7%)
 Black14 (10.1%)159 (8.3%)
 Other8 (5.8%)133 (7.0%)
Year of diagnosis0.367
 2004–200954 (39.1%)823 (43.1%)
 2010–201584 (60.9%)1088 (56.9%)
Spanish-Hispanic-Latino (n%)0.372
 Yes17 (12.3%)289 (15.1%)
 No121 (87.7%)1622 (84.9%)
MTC subtypes (n%)0.622
 MTC with amyloid stroma4 (2.9%)71 (3.7%)
 MTC NOSa134 (97.1%)1840 (93.2%)
Laterality (n%)0.419
 Unilateral138 (100%)1902 (99.5%)
 Bilateral0 (0%)9 (0.5%)
Multifocality (n%)0.009
 Solitary tumor86 (62.3%)1388 (72.6%)
 Multifocal tumor52 (37.7%)523 (37.7%)
Tumor size (n%)<0.001
 ≤227 (19.6%)1030 (53.9%)
 2–446 (33.3%)594 (31.1%)
 ≥465 (47.1%)287 (15.0%)
Extrathyroidal extension (n%)<0.001
 Yes57 (41.3%)309 (16.2%)
 No81 (58.7%)1602 (83.8%)
Lymph node metastasis (n%)<0.001
 No24 (17.4%)1206 (63.1%)
 Cervical central lymph node36 (26.1%)288 (15.1%)
 Cervical lateral lymph node70 (50.7%)359 (18.8%)
 Yes NOS8 (5.8%)58 (3.0%)

MTC, medullary thyroid carcinoma; DM, distant metastasis; NOS, not otherwise specified.